Expression of platelet-activating factor receptor: A novel prognosticator in patients with hepatocellular carcinoma following hepatectomy

Oncology

Volumn 72, Issue 5-6, 2008, Pages 381-387

  Kitagawa, Dai ^a   Taketomi, Akinobu ^a   Kayashima, Hiroto ^a   Kuroda, Yosuke ^a   Itoh, Shinji ^a   Yamashita, Yo Ichi ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Platelet activating factor; Platelet activating factor receptor; Portal vein invasion; Prognosticator

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEINS; PROGNOSIS; RECEPTORS, G-PROTEIN-COUPLED; SURVIVAL ANALYSIS;

EID: 39049087028     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113149     Document Type: Article

References (38)

1. Demopoulos CA, Pinckard RN, Hanahan DJ: Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979;254:9355-9358.
2. Izumi T, Shimizu T: Platelet-activating factor: gene expression and signal transduction. Biochim Biophys Acta 1995;1259:317-333.
3. Ishii S, Shimizu T: Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 2000;39:41-82.
4. Ishii S, Nagase T, Tashiro F, Ikuta K, Sato S, Waga I, Kume K, Miyazaki J, Shimizu T: Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 1997;16:133-142.
5. Im SY, Ko HM, Ko YS, Kim JW, Lee HK, Ha TY, Lee HB, Oh SJ, Bai S, Chung KC, Lee YB, Kang HS, Chun SB: Augmentation of tumor metastasis by platelet-activating factor. Cancer Res 1996;56:2662-2665.
6. Melnikova VO, Mourad-Zeidan AA, Lev DC, Bar-Eli M: Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J Biol Chem 2006;281:2911-2922.
7. Montrucchio G, Sapino A, Bussolati B, Ghisolfi G, Rizea-Savu S, Silvestro L, Lupia E, Camussi G: Potential angiogenic role of platelet-activating factor in human breast cancer. Am J Pathol 1998;153:1589-1596.
8. Bussolati B, Biancone L, Cassoni P, Russo S, Rola-Pleszczynski M, Montrucchio G, Camussi G: PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol 2000;157:1713-1725.
9. Bussolati B, Russo S, Deambrosis I, Cantaluppi V, Volpe A, Ferrando U, Camussi G: Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis. Int J Cancer 2002;100:654-661.
10. 2+ levels and growth of human prostate cancer cells. Cell Signal 2004;16:959-965.
11. Boccellino M, Camussi G, Giovane A, Ferro L, Calderaro V, Balestrieri C, Quagliuolo L: Platelet-activating factor regulates cadherin-catenin adhesion system expression and β-catenin phosphorylation during Kaposi's sarcoma cell motility. Am J Pathol 2005;166:1515-1522.
12. Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G, Camussi G: Tumor necrosis factor α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 1994;180:377-382.
13. Ko HM, Seo KH, Han SJ, Ahn KY, Choi IH, Koh GY, Lee HK, Ra MS, Im SY: Nuclear factor κB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 2002;62:1809-1814.
14. Russo S, Bussolati B, Deambrosis I, Mariano F, Camussi G: Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction. J Immunol 2003;171:5489-5497.
15. Kume K, Shimizu T: Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor. J Biol Chem 1997;272:22898-22904.
16. Kotelevets L, Noë V, Bruyneel E, Myssiakine E, Chastre E, Mareel M, Gespach C: Inhibition by platelet-activating factor of src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. J Biol Chem 1998;273:14138-14145.
17. Faivre S, Régnauld K, Bruyneel E, Nguyen QD, Mareel M, Emami S, Gespach C: Suppression of cellular invasion by activated Gprotein subunits Gαo, Gαi1, Gαi2, and Gαi3 and sequestration of Gβγ. Mol Pharmacol 2001;60:363-372.
18. Wang H, Chakrabarty S: Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells. Oncogene 2003;22:2186-2191.
19. Denizot Y, Desplat V, Drouet M, Bertin F, Melloni B: Is there a role of platelet-activating factor in human lung cancer? Lung Cancer 2001;33:195-202.
20. Denizot Y, Armas RD, Caire F, Pommepuy I, Truffinet V, Labrousse F: Platelet-activating factor and human meningiomas. Neuropathol Appl Neurobiol 2006;32:674-678.
21. Mathonnet M, Descottes B, Valleix D, Truffinet V, Labrousse F, Denizot Y: Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma. World J Gastroenterol 2006;12:2773-2778.
22. Merendino N, Dwinell MB, Varki N, Eckmann L, Kagnoff MF: Human intestinal epithelial cells express receptors for platelet-activating factor. Am J Physiol 1999;277:G810-G818.
23. Zhou W, McCollum MO, Levine BA, Olson MS: Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology 1992;16:1236-1240.
24. Serizawa A, Nakamura S, Suzuki S, Baba S, Nakano M: Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion. Hepatology 1996;23:1656-1663.
25. Horie Y, Wolf R, Russell J, Shanley TP, Granger DN: Role of Kupffer cells in gut ischemia/reperfusion-induced hepatic microvascular dysfunction in mice. Hepatology 1997;26:1499-1505.
26. Sakaguchi T, Nakamura S, Suzuki S, Oda T, Ichiyama A, Baba S, Okamoto T: Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats. Hepatology 1999;30:959-967.
27. 4-induced cirrhotic rat liver. J Hepatol 2003;39:200-207.
28. Yang Y, Nemoto EM, Harvey SAK, Subbotin VM, Gandhi CR: Increased hepatic platelet activating factor (PAF) and PAF receptor in carbon tetrachloride induced liver cirrhosis. Gut 2004;53:877-883.
29. Grypioti AD, Theocharis SE, Demopoulos CA, Papadopoulou-Daifoti Z, Basayiannis AC, Mykoniatis MG: Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats. Liver Int 2006;26:97-105.
30. Honda Z, Takano T, Gotoh Y, Nishida E, Ito K, Shimizu T: Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J Biol Chem 1994;269:2307-2315.
31. Shimada A, Ota Y, Sugiyama Y, Sato S, Kume K, Shimizu T, Inoue S: In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. J Invest Dermatol 1998;110:889-893.
32. Deo DD, Bazan NG, Hunt JD: Activation of platelet-activating factor receptor-coupled Gαq leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells. J Biol Chem 2004;279:3497-3508.
33. Berthou C, Bourge JF, Zhang Y, Soulié A, Geromin D, Denizot Y, Sigaux F, Sasportes M: Interferon-γ-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis. Blood 2000;95:2329-2336.
34. Geromin D, Bourge JF, Soulié A, Pawliuk R, Fleet C, Michel E, Denizot Y, Berthou C, Leboulch P, Sigaux F, Sasportes M: Glycoprotein 170 induces platelet-activating factor receptor membrane expression and confers tumor cell hypersensitivity to NK-dependent cell lysis. J Immunol 2004;172:3604-3611.
35. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K: Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 1998;83:58-63.
36. Wang H, Tan X, Chang H, Gonzalez-Crussi F, Remick DG, Hsueh W: Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumor necrosis factor. Biochem J 1997;322:603-608.
37. Dupré DJ, Chen Z, Gouill CL, Thériault C, Parent JL, Rola-Pleszczynski M, Stankova J: Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor. J Biol Chem 2003;278:48228-48235.
38. Osada T, Sakamoto M, Nishibori H, Iwaya K, Matsuno Y, Muto T, Hirohashi S: Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver. J Hepatol 1997;26:1266-1273.